| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780094 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
The Pipelle is the more cost-effective sampling strategy compared to D&C for EC diagnosis in women with PMB. From the cost-effectiveness perspective, the higher sampling failure rate of Pipelle should not be regarded as a limitation in its clinical application.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Yan Yi, Cindy L. Bryce, Shalkar Adambekov, Robert P. Edwards, Sharon L. Goughnour, Faina Linkov,